DBC-664 in Adult Patients With Solid Tumors
DBC-664 in Adult Patients With Solid Tumors
Recruiting · NCT07705035 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DBC-664 in Adult Patients With Solid Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, carcinoma, endometrium adenocarcinoma, epithelial neoplasm, lung adenocarcinoma, lung neoplasm, malignant germ cell tumor, neoplasm, ovarian adenocarcinoma, respiratory tract neoplasm, transitional cell carcinoma, urothelial carcinoma | Recruiting | Phase 1 | 2026-09-29 | NCT07705035 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duboce Biopharmaceuticals, Inc. | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sarah Cannon Research Institute - Denver HealthONE | Denver | United States | 1 |
| Scri Oncology Partners | Nashville | United States | 156 |
| START Midwest | Grand Rapids | United States | 79 |
| START New Jersey | East Brunswick | United States | 16 |
| START New York | Lake Success | United States | 1 |
| START San Antonio | San Antonio | United States | 30 |